Endo International
Endo to withdraw FDA application for abuse-deterrent labelling on opioid drug
August 15, 2016Sales and Marketing Endo, Endo International, abuse deterrent, opioid
Endo International has announced that, following discussions with the US Food and Drug Administration (FDA), it has decided to withdraw …
Endo shares plunge almost 40% as company cuts FY outlook
May 9, 2016Sales and Marketing Endo International, earnings, outlook, revenue
Shares in Endo International (Nasdaq: ENDP) plunged to close down nearly 40% after the company cut its full-year earnings forecast …
FTC files complaint against Endo for blocking generics of its pain drugs
April 1, 2016Business Services, Manufacturing and Production, Medical Communications, Sales and Marketing Endo International, FTC, legal, regulation
The US Federal Trade Commission (FTC) has filed a complaint against Endo International (Nasdaq: ENDP) alleging the company used illegal …
Latest content
NIHR chief scientific adviser visits Huddersfield health innovation campus
September 25, 2026
One in three UK women with migraine say symptoms taken less seriously
September 24, 2026
Report highlights scope to expand day surgery
September 23, 2026
Sygnature formalises drug discovery collaboration with X-Chem
September 22, 2026
Codis appoints Steven Facer as chief commercial officer
September 21, 2026
